Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis.
H Fu, C Ma, L Tang, F Wu, B Liu… - The Quarterly Journal of …, 2014 - europepmc.org
Aim We aim to assess the effects of recombinant human thyrotropin (rhTSH) versus thyroid
hormone withdrawal (THW), and rhTSH-aided low doses (1.11 GBq and 1.85 GBq) versus …
hormone withdrawal (THW), and rhTSH-aided low doses (1.11 GBq and 1.85 GBq) versus …
rhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer: a meta-analysis
C Ma, L Tang, H Fu, J Li, H Wang - Nuclear Medicine …, 2013 - journals.lww.com
The effects of low-activity versus high-activity radioiodine regimens in thyroid remnant
ablation for patients with differentiated thyroid carcinoma (DTC) under recombinant human …
ablation for patients with differentiated thyroid carcinoma (DTC) under recombinant human …
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
B Biondi, M Pulcrano, L Pagano… - Biologics: Targets and …, 2009 - Taylor & Francis
Various studies have demonstrated the safety and efficacy of recombinant human thyroid-
stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was …
stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was …
Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational …
ANA van der Horst-Schrivers, WJ Sluiter… - Plos one, 2015 - journals.plos.org
Introduction Patients with differentiated thyroid cancer (DTC) are treated with (near)-total
thyroidectomy followed by remnant ablation. Optimal radioiodine-131 (131I) uptake is …
thyroidectomy followed by remnant ablation. Optimal radioiodine-131 (131I) uptake is …
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario
A Campennì, L Giovanella, SA Pignata… - Nuclear Medicine …, 2015 - journals.lww.com
Objective Differentiated thyroid cancer is rare, but the incidence has been increasing in the
last few decades. Early treatment is based on surgery and thyroid remnant ablation (TRA) by …
last few decades. Early treatment is based on surgery and thyroid remnant ablation (TRA) by …
Thyroid remnant ablation success and disease outcome in stage III or IV differentiated thyroid carcinoma: recombinant human thyrotropin versus thyroid hormone …
VC JA, MB LM, G Moreno, RJ Marlowe… - The Quarterly Journal …, 2015 - europepmc.org
Background Most publications to date compare outcomes after post-surgical thyroid remnant
ablation stimulated by recombinant human thyrotropin (rhTSH) versus thyroid hormone …
ablation stimulated by recombinant human thyrotropin (rhTSH) versus thyroid hormone …
[HTML][HTML] HiLo: Multicentre randomized phase III clinical trial of high vs low dose radioiodine, with or without recombinant human thyroid stimulating hormone (rhTSH) …
U Mallick, C Harmer, S Clarke, L Moss, A Nicol… - 2012 - osti.gov
Recommended treatment for most patients with differentiated thyroid cancer is surgery
followed by radioiodine ablation. Current practice in many centres is to use a high …
followed by radioiodine ablation. Current practice in many centres is to use a high …
The effectiveness of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal prior to radioiodine remnant ablation in thyroid cancer: a …
We evaluated the efficacy of recombinant human thyroid-stimulating hormone (rhTSH)
versus thyroid hormone withdrawal (THW) prior to radioiodine remnant ablation (RRA) in …
versus thyroid hormone withdrawal (THW) prior to radioiodine remnant ablation (RRA) in …
Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
A Piccardo, M Puntoni, G Ferrarazzo, L Foppiani… - European journal of …, 2018 - Springer
Purpose Current guidelines recommend thyroid hormone withdrawal (THW) of 3–4 weeks
before radioiodine remnant ablation (RRA) of differentiated thyroid carcinoma (DTC). We …
before radioiodine remnant ablation (RRA) of differentiated thyroid carcinoma (DTC). We …
A “new/old method” for TSH stimulation: could a third way to prepare DTC patients for 131I remnant ablation possibly exist?
L Giovanella, A Piccardo - European Journal of Nuclear Medicine and …, 2016 - Springer
A growing body of evidence supported the possibility to prepare patients affected by
differentiated thyroid cancer (DTC) at low and/or intermediate risk with recombinant human …
differentiated thyroid cancer (DTC) at low and/or intermediate risk with recombinant human …